Spike Another API Approved for Marketing
Release time:
2023-05-04
Peak Pharmaceutical's Fluprost API submitted its API registration information to the Drug Evaluation Center (CDE) of the State Drug Administration in February 2021, which was accepted and started the technical review in March of that year, and received a notice of issuance at the end of the year. In May 2022, the pharmaceutical company submitted supplementary research materials to the Drug Examination Center, and at the same time sent samples to Zhejiang Food and Drug Inspection Institute for partial quality standard review after the supplementary research. In September 2022, the Drug Review Center initiated the technical review of supplementary research data, and the final review results were in line with the relevant national technical standards for the review of APIs and approved for sale in the domestic market.
Tasfluprost is a prostaglandin analog. It is a selective prostaglandin receptor agonist. It can reduce intraocular pressure by increasing the outflow of aqueous humor through the uveoscleral route. It is used to reduce the increase of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Including Peak Pharmaceuticals, there are currently only two companies that have approved the listing of the API in China. The successful listing of the raw material drug of He Fluoroprost enriches the products of Peak Pharmaceuticals and helps to further expand the business areas of the company's pharmaceutical sector. (Xu Chunliu)
More information
The company's vocational skill level independently identifies two new occupations
A few days ago, after the examination and approval of the Jinhua Municipal Bureau of Human Resources and Social Security, and reported to the Provincial Department of Human Resources and Social Security for examination and filing, Jianfeng Group's independent identification level of vocational skills was based on last year. Two new occupations (types of work) are chemical inspectors and organic synthesis workers.
2022
05-20
On May 12, Cai Xiaochun, deputy secretary of the Party group of Zhejiang Federation of industry and commerce, and his party visited Jianfeng group for investigation, visited Jinxi factory area of Jianfeng pharmaceutical factory and Jinxi internationalization project site, and had a discussion with Jiang Xiaomeng, chairman of the group company, Huang Jinlong, deputy general manager of the group company and general manager of the pharmaceutical company.
2022
05-20
On the afternoon of April 6, Jiang Xiaomeng, chairman of the group company, was invited to participate in the Jinhua News Client Financial Media Interview column "Night Talk of the Two Sessions", as a representative of the Jinhua Municipal People's Congress, to talk about suggestions for the future development of Jinhua enterprises. As the chairman of the Jinhua City Federation of Industry and Commerce, Jiang Xiaomeng has a personal experience of various problems encountered in the development of Jinhua enterprises. After careful investigation and full preparation, he put forward two proposals on strengthening the empowerment and allocation of production factors and further enhancing the market competitiveness of enterprises in our city and further promoting the compliance construction of private enterprises in our city and reducing the risk of enterprise operation. In the "two sessions night talk" interview, he put forward his own views on these two topics.
2022
04-12
Group Companies Commend 2021 Advanced
On the morning of January 26, the group company held the 2021 annual summary commendation meeting to review the work of the previous year, make arrangements for the work of 2022, sign the 2022 economic responsibility system with various professional companies and directly affiliated enterprises, and solemnly commend the 2021 advanced collectives and individuals.
2022
02-08
Group Company Convenes Workers' Representative and Trade Union Member Representative Conference
The group company held a representative meeting of staff representatives and trade union members, elected members of the eighth trade union committee and members of various special committees, and Shi Fu was elected chairman of the eighth trade union of the group trade union.
2022
02-08
The group company held an annual safety and environmental protection work conference to comprehensively summarize and review the safety and environmental protection work in 2021, make arrangements for the safety and environmental protection work in 2022, and sign the safety and environmental protection work responsibility system.
2022
02-08